154 related articles for article (PubMed ID: 1743375)
41. Malignant melanomas masquerade--as benign naevi.
Burge TS
J R Army Med Corps; 1992 Feb; 138(1):38-9. PubMed ID: 1578433
[TBL] [Abstract][Full Text] [Related]
42. High expression of cytoplasmic phosphorylated CSE1L in malignant melanoma but not in benign nevi: phosphorylated CSE1L for the discrimination between melanoma and benign nevi.
Chin SY; Wu PR; Shih YH; Yeh CM; Lee WR; Shen SC; Yeh KT; Jiang MC; Tseng JT
Int J Clin Exp Pathol; 2015; 8(2):1393-401. PubMed ID: 25973023
[TBL] [Abstract][Full Text] [Related]
43. Nucleolar organizer regions in determining malignancy of pigmented conjunctival lesions.
Saornil MA; Marcus DM; Doepner D; Apolone G; Torre V; Albert DM
Am J Ophthalmol; 1993 Jun; 115(6):800-5. PubMed ID: 8506916
[TBL] [Abstract][Full Text] [Related]
44. Melanocytic nevi in histologic association with primary cutaneous melanoma of superficial spreading and nodular types: effect of tumor thickness.
Sagebiel RW
J Invest Dermatol; 1993 Mar; 100(3):322S-325S. PubMed ID: 8440914
[TBL] [Abstract][Full Text] [Related]
45. Significant melanocytic lesions in infancy, childhood, and adolescence.
Hoss DM; Grant-Kels JM
Dermatol Clin; 1986 Jan; 4(1):29-44. PubMed ID: 3521978
[TBL] [Abstract][Full Text] [Related]
46. Proteomic Mass Spectrometry Imaging for Skin Cancer Diagnosis.
Lazova R; Seeley EH
Dermatol Clin; 2017 Oct; 35(4):513-519. PubMed ID: 28886807
[TBL] [Abstract][Full Text] [Related]
47. Dermoscopic features of common nevi: a review.
Kim JK; Nelson KC
G Ital Dermatol Venereol; 2012 Apr; 147(2):141-8. PubMed ID: 22481577
[TBL] [Abstract][Full Text] [Related]
48. Expression of two morphologic parameters concerning tumor-stroma interaction in benign and malignant melanocytic skin lesions.
Fink-Puches R; Smolle J; Hofmann-Wellenhof R; Kerl H
Am J Dermatopathol; 1998 Oct; 20(5):468-72. PubMed ID: 9790107
[TBL] [Abstract][Full Text] [Related]
49. The early and intermediate precursor lesions of tumor progression in the melanocytic system: common acquired nevi and atypical (dysplastic) nevi.
Elder DE; Clark WH; Elenitsas R; Guerry D; Halpern AC
Semin Diagn Pathol; 1993 Feb; 10(1):18-35. PubMed ID: 8506414
[TBL] [Abstract][Full Text] [Related]
50. Differentiation between Spitz nevi and malignant melanomas by interphase fluorescence in situ hybridization.
Wettengel GV; Draeger J; Kiesewetter F; Schell H; Neubauer S; Gebhart E
Int J Oncol; 1999 Jun; 14(6):1177-83. PubMed ID: 10339676
[TBL] [Abstract][Full Text] [Related]
51. Proliferative activity in the malignant cellular blue nevus.
Pich A; Chiusa L; Margaria E; Aloi F
Hum Pathol; 1993 Dec; 24(12):1323-9. PubMed ID: 7903955
[TBL] [Abstract][Full Text] [Related]
52. The utility of PRAME staining in identifying malignant transformation of melanocytic nevi.
Lohman ME; Steen AJ; Grekin RC; North JP
J Cutan Pathol; 2021 Jul; 48(7):856-862. PubMed ID: 33433032
[TBL] [Abstract][Full Text] [Related]
53. Melanocytic nevi simulant of melanoma with medicolegal relevance.
Massi G
Virchows Arch; 2007 Sep; 451(3):623-47. PubMed ID: 17653760
[TBL] [Abstract][Full Text] [Related]
54. Common acquired melanocytic nevi, melanocytic dysplasia and malignant melanoma. A morphometric study.
Santucci M; Urso C; Giannini A; Bondi R
Appl Pathol; 1989; 7(2):111-5. PubMed ID: 2730799
[TBL] [Abstract][Full Text] [Related]
55. [Use of the AgNOR method for the differential diagnosis of tumors and for the quantification of non-neoplastic epidermal hyperproliferation in dermatohistology].
Heinisch G; Barth J
Zentralbl Pathol; 1994 Mar; 140(1):95-101. PubMed ID: 7515680
[TBL] [Abstract][Full Text] [Related]
56. hTERT expression in melanocytic lesions: an immunohistochemical study on paraffin-embedded tissue.
Fullen DR; Zhu W; Thomas D; Su LD
J Cutan Pathol; 2005 Nov; 32(10):680-4. PubMed ID: 16293180
[TBL] [Abstract][Full Text] [Related]
57. Significance of dermoscopic patterns in detecting malignant melanoma on acral volar skin: results of a multicenter study in Japan.
Saida T; Miyazaki A; Oguchi S; Ishihara Y; Yamazaki Y; Murase S; Yoshikawa S; Tsuchida T; Kawabata Y; Tamaki K
Arch Dermatol; 2004 Oct; 140(10):1233-8. PubMed ID: 15492186
[TBL] [Abstract][Full Text] [Related]
58. Nucleolar organizer regions and image analysis nuclear morphometry of small cell (nevoid) melanoma.
Kossard S; Wilkinson B
J Cutan Pathol; 1995 Apr; 22(2):132-6. PubMed ID: 7560345
[TBL] [Abstract][Full Text] [Related]
59. The value of nucleolar organizer regions in uveal melanoma. The Collaborative Ocular Melanoma Study Group.
Marcus DM; Minkovitz JB; Wardwell SD; Albert DM
Am J Ophthalmol; 1990 Nov; 110(5):527-34. PubMed ID: 1700611
[TBL] [Abstract][Full Text] [Related]
60. Nuclear and cytoplasmic features in the diagnosis of Clark's nevi.
Valdebran M; Bandino J; Elbendary A; Gad A; Arudra KC; de Feraudy S; Elston DM
J Cutan Pathol; 2018 Mar; 45(3):204-207. PubMed ID: 29193203
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
